AbbVie announced the European Commission approved RINVOQ® as the first oral Janus Kinase inhibitor for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
argenx SE and Genmab A/S announced that argenx and Genmab have entered into a collaboration agreement to jointly discover, develop and commercialize novel therapeutic antibodies with applications in immunology, as well as in oncology therapeutic areas.
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, presented promising preclinical data on its novel oncolytic virus TG6050, at the American Association for Cancer Research Annual Meeting, April 14-19, 2023.
Abbisko announced the results of five latest preclinical studies at the 2023 American Association for Cancer Research annual meeting.
Abbisko presents the research results of 5 programs at the 2023 AACR Annual Meeting Read More »
As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched in China.
Henlius Achieved Steep Revenue Growth in Q1 2023, Core Products Sales Surged Read More »
Complement Therapeutics GmbH, a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases, announced the completion of a €72 million Series A financing.
Clinical results for experimental treatments in Alzheimer’s, ALS and more are expected over the coming months. BioSpace highlights a few of the more highly anticipated datasets.
MBT Mycobacteria IVD Kit optimizes sample preparation and comprehensive library of MBT HT Mycobacteria IVD Module MBT Mycobacteria IVD Kit optimizes sample preparation and comprehensive library of MBT HT Mycobacteria IVD Module MBT HT Filamentous Fungi IVD Module incorporates extensive fungal library with easy and effective sample preparation (MyT) New MBT Compass HT IVD software
UnitedHealth’s growth, which resulted in a profit of $5.8 billion in the quarter, was “stronger than normal,” one analyst said.
UnitedHealth notches record revenue in first quarter Read More »
